These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 19497432)

  • 21. Impact of androgen receptor cytosine-adenine-guanine polymorphisms on clinical outcome in BRCA mutation-associated epithelial ovarian cancers.
    Li AJ; McAllister P; Karlan BY
    Gynecol Oncol; 2010 Jan; 116(1):105-8. PubMed ID: 19818997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Problems in analysis of large-scale data: gene expression microarray analysis].
    Yamada R; Ueda H
    Tanpakushitsu Kakusan Koso; 2009 Aug; 54(10):1307-15. PubMed ID: 19798829
    [No Abstract]   [Full Text] [Related]  

  • 23. Bibliography. Current world literature. Gynecologic cancer.
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):82-93. PubMed ID: 17218857
    [No Abstract]   [Full Text] [Related]  

  • 24. Gynecologic cancer genomics in the modern era.
    Levine DA; Swisher EM
    Gynecol Oncol; 2013 Mar; 128(3):407-8. PubMed ID: 23399003
    [No Abstract]   [Full Text] [Related]  

  • 25. Investigating the effectiveness of DNA microarray analysis for identifying the genes involved in l-lactate production by Saccharomyces cerevisiae.
    Hirasawa T; Ookubo A; Yoshikawa K; Nagahisa K; Furusawa C; Sawai H; Shimizu H
    Appl Microbiol Biotechnol; 2009 Oct; 84(6):1149-59. PubMed ID: 19727705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of 1,25(OH)2D3 and its structural analogs on gene expression in cancer cells--a microarray approach.
    Kriebitzsch C; Verlinden L; Eelen G; Tan BK; Van Camp M; Bouillon R; Verstuyf A
    Anticancer Res; 2009 Sep; 29(9):3471-83. PubMed ID: 19667141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hereditary predispositions to gynaecological cancers].
    Espié M
    Gynecol Obstet Fertil; 2006 May; 34(5):460. PubMed ID: 16630743
    [No Abstract]   [Full Text] [Related]  

  • 28. Gene expression changes in an animal model of in utero irradiation-induced Cortical Dysplasia.
    Hiremath GK; Tilelli CQ; Xu Y; Gopalan B; Najm IM
    Epileptic Disord; 2009 Sep; 11(3):232-43. PubMed ID: 19720584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical value of morphometric and DNA flow cytometric variables as independent predictors of survival in epithelial ovarian carcinoma: a 5-year follow-up study.
    Veerman MM; van der Wurff AA; van de Water M; Kruitwagen RF; Feijen HW; Vos MC
    Int J Gynecol Pathol; 2009 Sep; 28(5):432-41. PubMed ID: 19696612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microarray data analysis for differential expression: a tutorial.
    Suárez E; Burguete A; Mclachlan GJ
    P R Health Sci J; 2009 Jun; 28(2):89-104. PubMed ID: 19530550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of suitable reference genes for gene expression studies of human serous ovarian cancer by real-time polymerase chain reaction.
    Li YL; Ye F; Hu Y; Lu WG; Xie X
    Anal Biochem; 2009 Nov; 394(1):110-6. PubMed ID: 19622337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRCA2 alteration is important in clear cell carcinoma of the ovary.
    Goodheart MJ; Rose SL; Hattermann-Zogg M; Smith BJ; De Young BR; Buller RE
    Clin Genet; 2009 Aug; 76(2):161-7. PubMed ID: 19656163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression profiling of copper-induced responses in the intertidal copepod Tigriopus japonicus using a 6K oligochip microarray.
    Ki JS; Raisuddin S; Lee KW; Hwang DS; Han J; Rhee JS; Kim IC; Park HG; Ryu JC; Lee JS
    Aquat Toxicol; 2009 Jul; 93(4):177-87. PubMed ID: 19515434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.
    Ross JS
    Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of a risk scoring system to predict surgical adverse events in the management of epithelial ovarian cancers.
    Li AJ
    Gynecol Oncol; 2009 Dec; 115(3):323-4. PubMed ID: 19883850
    [No Abstract]   [Full Text] [Related]  

  • 36. cDNA microarray analysis of serially sampled cervical cancer specimens from patients treated with thermochemoradiotherapy.
    Borkamo ED; Schem BC; Fluge Ø; Bruland O; Dahl O; Mella O
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1562-9. PubMed ID: 19931738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Oncogenes in gynecological malignancies].
    Zhang X
    Zhonghua Fu Chan Ke Za Zhi; 1995 Nov; 30(11):643-6. PubMed ID: 8745485
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cytogenetics of female genital cancer].
    Pescetto G; De Cecco L
    Minerva Med; 1967 May; 58(35):1669-70. PubMed ID: 6028214
    [No Abstract]   [Full Text] [Related]  

  • 39. Between the quality of life and curability of the disease.
    Yen CF; Lee CL
    J Minim Invasive Gynecol; 2009; 16(3):245-6. PubMed ID: 19423055
    [No Abstract]   [Full Text] [Related]  

  • 40. New development of the FIGO staging system.
    Odicino F; Tisi G; Rampinelli F; Miscioscia R; Sartori E; Pecorelli S
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S8-9. PubMed ID: 17761268
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.